NATIONAL BRAIN TUMOR SOCIETY INC
NATIONAL BRAIN TUMOR SOCIETY INC
NATIONAL BRAIN TUMOR SOCIETY INC
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$17,010,470
Cash & Equivalents
49%
Investments
41%
Receivables (Non-Related)
6%
Prepaid Expenses
2%
Other Assets
1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$912,822
Payables & Accruals
56%
Grants Payable
27%
Other Liabilities
17%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$12,469,607
$8,351,612
-33%
Receivables (Non-Related)
$1,151,705
$1,033,647
-10%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$280,305
$321,815
+15%
Investments
$1,592,691
$7,050,524
+343%
Property, Plant, & Equipment (net)
$155,168
$74,556
-52%
Other Assets
$312,495
$178,316
-43%
Total Assets
$15,961,971
$17,010,470
+7%
Liabilities
2023
2024
Change
Payables & Accruals
$398,767
$509,434
+28%
Grants Payable
-
$250,000
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$276,374
$153,388
-44%
Total Liabilities
$675,141
$912,822
+35%
Net assets
2023
2024
Change
Restricted Net Assets
$5,138,368
$5,519,974
+7%
Unrestricted Net Assets
$10,148,462
$10,577,674
+4%
Net assets
2023
2024
Change
Net assets
+$15,286,830
+$16,097,648
+5%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)